Biotech News 21 Nov 2024 Bolstering Pertussis Surveillance in Latin America As antimicrobial resistance (AMR) continues to pose a critical global health challenge, rising pertussis cases (whooping cough) and increasing evidence of macrolide-resistant Bordetella pertussis around the world… Pantitra
Biotech News 19 Nov 2024 Whooping cough vaccine urged for children The Ministry of Public Health is encouraging people, especially children and those in physical contact with them, to get vaccinated… Pantitra
Biotech News 19 Aug 2024 Whooping cough cases more than 3 times higher than last year in return to pre-pandemic levels More than 10,800 cases have been recorded this year so far Cases of whooping cough are more than three times higher this… Pantitra
Biotech News 16 Jul 2024 UKHSA encourages timely vaccination as whooping cough cases rise New data published today by the UK Health Security Agency (UKHSA) shows cases of whooping cough continue to increase with… Pantitra
Biotech News 21 Jun 2024 Why are whooping cough infections surging in Australia and should you get a booster jab? Health experts say the rise is no surprise given the last pertussis epidemic was eight years ago, and urge people… Pantitra
Biotech News 29 Apr 2024 With whooping cough cases on the rise, do you need a booster vaccine? Cases of pertussis are particularly dangerous for babies, experts warn — here's what to know for all ages As whooping… Pantitra
BioNet News, Pertussis, Publication 14 Jul 2021 Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines It is increasingly understood that acellular pertussis vaccines are associated with rapid waning of vaccine-induced immune responses and a… Supachai
